Notice: 函数 WP_Styles::add 的调用方法不正确。 The style with the handle "storefront-woocommerce-style" was enqueued with dependencies that are not registered: storefront-style. 请查阅调试 WordPress来获取更多信息。 (这个消息是在 6.9.1 版本添加的。) in /wordpress/wp-includes/functions.php on line 6260

KC-4041

293T-human-KLK2-Cell-Line

Home » 293T-human-KLK2-Cell-Line

Background of 293T-human-KLK2-Cell-Line

KLK2 is a serine protease, which is closely related to the occurrence and development of malignant tumors. Loss of KLK2 expression is a potentially useful prognostic marker in prostate cancer. This provides a new perspective on disease progression and new therapeutic targets.

Specifications

Catalog Number:
KC-4041
Cell Line Name:
293T-human-KLK2-Cell-Line
Clone Number
Host Cell Line:
293T
Description:
Stable HEK293T clone expressing exogenous human KLK2 gene
Quantity:
Two vials of frozen cells (2-5×106/vial)
Stability:
Stable in culture over a minimum of 10 passages
Application:
Drug screening and biological assays
Freezing Medium:
70% DMEM + 20% FBS + 10% DMSO
Propagation Medium:
DMEM + 10% FBS + 1μg/mL Puromycin
Selection Marker:
Puromycin
Morphology:
Epithelial
Subculture:
Split saturated culture 1:4-1:8 every 2-3 days; seed out at about 1-3 × 105 cells/mL
Incubation:
37 °C with 5% CO2
Storage:
Liquid nitrogen immediately upon receiving
Doubling Time:
Approximately 30 hours
Mycoplasma Status:
Negative
In Vivo Validation:
NA

Cell Line Generation

293T human KLK2 cell line was generated using a lentiviral vector expressing the human KLK2 sequence.

Characterization

Figure 1: Characterization of human KLK2 overexpression in the 293T human KLK2 stable clone using qPCR.

Cell Resuscitation

  1. Prewarm culture medium (DMEM supplemented with 10% FBS and 1μg/mL puromycin)in a 37°C water bath.
  2. Thaw the frozen vial in a 37°C water bath for 1-2 minutes.
  3. Transfer the vial into biosafety cabinet, and wipe the surface with 70% ethanol.
  4. Unscrew the top of the vial and transfer the cell suspension gently into a sterile centrifuge tube containing 9.0mL complete culture medium.
  5. Spin at ~ 125 × g for 5-7 minutes at room temperature, and discard the supernatant without disturbing the pellet.
  6. Resuspend cell pellet with the appropriate volume of complete medium and transfer the cell suspension into a T25 culture flask.
  7. Incubate the flask at 37°C, 5% CO2 incubator.
  8. Split saturated culture 1:4-1:8 every 2-3 days; seed out at about 1-3 × 105 cells/mL.

Cell Freezing

  1. Prepare the freezing medium (70% DMEM + 20% FBS + 10% DMSO) fresh immediately before use.
  2. Keep the freezing medium on ice and label cryovials.
  3. Transfer cells to a sterile, conical centrifuge tube, and count the cells.
  4. Centrifuge the cells at 250×g for 5 minutes at room temperature and carefully aspirate off the medium.
  5. Resuspend the cells at a density of at least 3×106 cells/mL in chilled freezing medium.
  6. Aliquot 1 mL of the cell suspension into each cryovial.
  7. Freeze cells in the CoolCell freezing container overnight in a -80°C freezer.
  8. Transfer vials to liquid nitrogen for long-term storage

References

  1. Hong SK. Kallikreins as biomarkers for prostate cancer. Biomed Res Int. 2014;2014:526341. doi: 10.1155/2014/526341. Epub 2014 Apr 7. PMID: 24809052; PMCID: PMC3997884.
  2. Meng G, Li P, Li M, Wu Y, Ma Y, Sun T, Ji C. KLK2 single-nucleotide polymorphism rs198977 is associated with increased susceptibility and hyperleukocytosis in AML. Front Genet. 2023 Aug 1;14:1218523. doi: 10.3389/fgene.2023.1218523. PMID: 37593117; PMCID: PMC10427912.
  3. Bonk S, Kluth M, Jansen K, Hube-Magg C, Makrypidi-Fraune G, Höflmayer D, Weidemann S, Möller K, Uhlig R, Büscheck F, Luebke AM, Burandt E, Clauditz TS, Steurer S, Schlomm T, Huland H, Heinzer H, Sauter G, Simon R, Dum D. Reduced KLK2 expression is a strong and independent predictor of poor prognosis in ERG-negative prostate cancer. Prostate. 2020 Sep;80(13):1097-1107. doi: 10.1002/pros.24038. Epub 2020 Jul 6. PMID: 32628300.